HomeClinical TopicsFDA approves new drug for skin infections

FDA approves new drug for skin infections

On August 6, the U.S. Food and Drug Administration (FDA) approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content